Kraematon Investment Advisors Inc. Trims Stock Position in Innovator IBD 50 ETF $FFTY

Kraematon Investment Advisors Inc. lessened its stake in shares of Innovator IBD 50 ETF (NYSEARCA:FFTY) by 49.4% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 37,922 shares of the company’s stock after selling 37,050 shares during the period. Kraematon Investment Advisors Inc. owned about 1.76% of Innovator IBD 50 ETF worth $761,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of FFTY. Concurrent Investment Advisors LLC lifted its holdings in shares of Innovator IBD 50 ETF by 11.1% in the 2nd quarter. Concurrent Investment Advisors LLC now owns 63,128 shares of the company’s stock worth $3,349,000 after buying an additional 6,321 shares during the period. LPL Financial LLC increased its stake in shares of Innovator IBD 50 ETF by 13.1% during the fourth quarter. LPL Financial LLC now owns 52,786 shares of the company’s stock valued at $1,837,000 after buying an additional 6,098 shares during the period. BNP Paribas Financial Markets bought a new stake in shares of Innovator IBD 50 ETF in the third quarter valued at about $1,494,000. WorthPointe LLC raised its holdings in shares of Innovator IBD 50 ETF by 18.3% in the second quarter. WorthPointe LLC now owns 24,412 shares of the company’s stock valued at $1,295,000 after acquiring an additional 3,771 shares in the last quarter. Finally, Bank of America Corp DE lifted its stake in Innovator IBD 50 ETF by 56.0% in the third quarter. Bank of America Corp DE now owns 19,419 shares of the company’s stock worth $725,000 after acquiring an additional 6,971 shares during the period.

Innovator IBD 50 ETF Price Performance

Shares of Innovator IBD 50 ETF stock opened at $36.28 on Friday. Innovator IBD 50 ETF has a 1 year low of $31.61 and a 1 year high of $44.08. The firm’s 50-day moving average is $38.13 and its two-hundred day moving average is $38.40. The stock has a market cap of $78.00 million, a price-to-earnings ratio of 30.34 and a beta of 1.45.

Innovator IBD 50 ETF Profile

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.